Press release
Global Mumps Vaccine (MumpsVax) Market Outlook 2025-2034: Drivers, Innovations, And Future Outlook
Mumps Vaccine (MumpsVax) Market Analysis
What Is the Mumps Vaccine (MumpsVax) Market Size and Projected Growth Rate?
In recent times, the mumps vaccine (mumpsvax) market has experienced a significant growth. The market size is projected to expand from $2,057.93 million in 2024 to $2,210.59 million in 2025, with a compound annual growth rate (CAGR) of 7.4%. The substantial growth in the historical period is a result of higher pediatric vaccination rates, the rise of global health initiatives, improved public confidence in vaccines, increased awareness about diseases while traveling, and more extensive immunization campaigns.
Anticipated to witness robust expansion in the near future, the market for mumps vaccine (mumpsvax) is slated to reach a valuation of $2,902.21 million by 2029, growing at a compound annual growth rate (CAGR) of 7.0%. This predicted escalation during the forecast period is attributable to the augmenting prevalence of disease avoidable via vaccination, expanded awareness regarding adult vaccination, escalating health mindfulness, growth in vaccination programs, and ascending international health drives. Foreseen tendencies during the forecast duration encompass tailored vaccination approaches, infusion of digital health, amplified surveillance mechanisms, research, and development concerning adult vaccination, along with the incorporation of artificial intelligence.
Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=19909
What Are the Major Segments in the Mumps Vaccine (MumpsVax) Market?
The mumps vaccine (mumpsvax) market covered in this report is segmented -
1) By Product Type: Monovalent; Combinational; Divalent; Trivalent; Other Product Types
2) By Age Group: Pediatric; Adult
3) By Distribution Channels: Hospital pharmacies; Drug Stores; Retail Pharmacies
4) By End-User: Pediatric Clinic; Hospitals; Non-Governmental Organization (NGOs); Other End-Users
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=19909&type=smp
What Are The Driving Mumps Vaccine (MumpsVax) Market Evolution?
The surge in the occurrence of infectious diseases is anticipated to drive the mumps vaccine (mumpsvax) market in the future. Such diseases, triggered by potentially harmful microbes like viruses, bacteria, or parasites, can spread between individuals or through polluted surroundings. The escalating spread of these diseases is heavily influenced by factors like urban lifestyle changes, global warming, globalization, and alterations in human behavior and demographic, which boost the proliferation and emergence of disease-causing pathogens. Mumpsvax, which primarily helps prevent mumps infection (an infectious disease triggered by the mumps virus) is usually a component of the MMR (measles, mumps, rubella) vaccine. For example, as per a report by the UK Health Security Agency from August 2024, the West Midlands region had the most number of measles cases (160 cases, or 44%) in 2023, followed by London with 122 cases (33%). Remarkably, 63% (232 cases) of the total cases were children under 10 years of age. Towards the end of the year, there was a significant surge in measles activity, with 157 new cases in December, compared to a mere 45 cases in November. Hence, the growing prevalence of infectious diseases is fueling the mumps vaccine (mumpsvax) market. Increased spending on healthcare is anticipated to facilitate the mumps vaccine (mumpsvax) market development in the future. This expenditure encompasses the total amount spent on healthcare services and goods, preventive measures, and public healthcare activities over a certain timeframe with the aim to enhance the health outcomes. Factors such as an aged population, disorders that are chronic in nature, advanced medicinal technology, expensive medications, inefficient cost models, and a heightened demand for healthcare services stimulate the rise in healthcare expenditure. This surge impacts the mumps vaccine (mumpsvax) market by increasing funds for vaccination campaigns, thus making the vaccine more accessible and enhancing public health outcomes through better immunization against mumps. For instance, a report by the Office for National Statistics from May 2024 states that the total healthcare expenditure saw a 5.6% nominal rise between 2022 to 2023, as opposed to a growth rate of 0.9% in 2022. Furthermore, total enduring health and social care expenditure saw a 2.8% real terms upswing in 2022. Therefore, the surge in healthcare expenditure is fueling the mumps vaccine (mumpsvax) market.
Which Firms Dominate The Mumps Vaccine (MumpsVax) Market Segments?
Major companies operating in the mumps vaccine (mumpsvax) market include Merck & Co. Inc., GlaxoSmithKline plc
Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/mumps-vaccine-mumpsvax-global-market-report
Which Is The Largest Region In The Mumps Vaccine (MumpsVax) Market?
North America was the largest region in the mumps vaccine (mumpsvax) market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the mumps vaccine (mumpsvax) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Mumps Vaccine (MumpsVax) Market?
2. What is the CAGR expected in the Mumps Vaccine (MumpsVax) Market?
3. What Are the Key Innovations Transforming the Mumps Vaccine (MumpsVax) Industry?
4. Which Region Is Leading the Mumps Vaccine (MumpsVax) Market?
Why This Report Matters:
Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.
Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.
Efficient Research: Quickly identify market growth, leading players, and major segments.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Mumps Vaccine (MumpsVax) Market Outlook 2025-2034: Drivers, Innovations, And Future Outlook here
News-ID: 4058760 • Views: …
More Releases from The Business Research Company
Future Perspectives: Key Trends Shaping the Ultrasonic Fingerprint Chip Module M …
The ultrasonic fingerprint chip module market is on the verge of remarkable expansion, driven by rapid technological advancements and increasing demand for enhanced security features in various sectors. As biometric security gains prominence across consumer electronics and other industries, this market is set to register substantial growth through the end of the decade. Let's explore the market size forecast, key players, emerging trends, and detailed segmentation shaping the ultrasonic fingerprint…
Global Trends Overview: The Rapid Evolution of the Smart Electric Meter Market
The smart electric meter market is gaining considerable attention as energy management becomes more sophisticated and integrated with modern technology. This sector is poised for notable expansion driven by advancements in communication infrastructure, analytics, and increasing demand for smarter energy solutions worldwide. Here is an overview of the market's valuation, key players, emerging trends, and segmentation.
Projected Growth and Market Size of the Smart Electric Meter Market
The smart electric meter…
Key Companies Leading Innovation and Growth in the Ultra Secure Smartphone Marke …
The ultra secure smartphone market is poised for significant expansion as privacy and data protection become ever more critical in today's digital world. With increasing cybersecurity demands from governments and enterprises, along with technological advancements, this sector is set to experience remarkable growth through 2030. Let's explore the market's size, key players, emerging trends, and segmentation in detail.
Projected Market Growth and Size of the Ultra Secure Smartphone Sector
The ultra…
Segment Analysis and Major Growth Areas in the Smart Bread Maker Market
The smart bread maker market is poised for significant expansion in the coming years, driven by evolving consumer preferences and advances in technology. As kitchens become smarter and health-conscious habits increase, these appliances are becoming an essential part of modern households. Let's explore the market size, key players, upcoming trends, and segmentation details shaping this industry's future.
Projected Market Growth of the Smart Bread Maker Market by 2030
The smart bread…
More Releases for Mumps
Global Measles Mumps And Rubella Mmr Vaccines Market Size by Application, Type, …
USA, New Jersey- According to Market Research Intellect, the global Measles Mumps And Rubella Mmr Vaccines market in the Internet, Communication and Technology category is projected to witness significant growth from 2025 to 2032. Market dynamics, technological advancements, and evolving consumer demand are expected to drive expansion during this period.
The market for measles, mumps, and rubella (MMR) vaccines is steadily expanding as a result of growing vaccination campaigns and greater…
Mumps Vaccine Market Expected to Reach $3.5 Billion by 2031
Mumps vaccine is the most efficient way of preventing mumps viral infection in children and elderly population. Mumps vaccine is mainly administered in the form of combination vaccine, which offers resistance against measles, mumps, and rubella virus infections. The vaccine has no side effects; however, some cases may encounter very mild fever or rash. In addition, in some pediatric patients, mumps vaccine is given in the form of MMRV vaccine,…
Mumps Vaccine Market Boosting Technologies, Industry Growth, Demand Status, Tren …
Measles, Mumps, and Rubella (MMR) vaccinations are a mixture of live viruses that are injected. The live viruses are inactivate and cannot reproduce in human cells while the immune system responds and defends against the infection. The MMR vaccine has a long-term effect. The MMR vaccine causes fever, rash, cough, body pain, headache, nausea and severe consequences such as ovaries and testicles infection, deafness, and in rare cases it leads…
Measles, Mumps and Rubella (MMR) Vaccines Market Opportunity Analysis, 2026 – …
Measles, mumps, and rubella are the three common contagious airborne diseases that are highly caused by virus transmitted by sneezing and coughing of the infected person, which could lead to serious complications or death among children. Vaccines of these diseases are sold as attenuated viral vaccines, manufactured in a lyophilised formulation, which requires reconstitution with water for injection diluent and are available in two forms i.e. monovalent as well as…
Mumps Market Estimated to Flourish by 2016 – 2024 : Persistence Market Researc …
Mumps is a contagious disease typically affecting children and caused by the mumps virus. The characteristic of this disease is the initial onset of headache, loss of appetite, muscle aches, tiredness and fever followed by the typical swelling of one or more salivary glands. The disease is transmitted from one person to the other through saliva and/or droplets. Although the symptoms vanish within few days of infection and are usually…
Mumps - Pipeline Review, H1 2017
ReportsWorldwide has announced the addition of a new report title Mumps - Pipeline Review, H1 2017 to its growing collection of premium market research reports.
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Mumps - Pipeline Review, H1 2017, provides an overview of the Mumps (Infectious Disease) pipeline landscape.
Mumps is a contagious disease that leads to painful swelling of the salivary glands. The mumps are caused by a virus.…
